Parnell has announced the acquisition of Noble Pharma LLC, a U.S.-based pharmaceutical manufacturer, according to the Securities Purchase Agreement dated November 26, 2025. With this strategic acquisition, Parnell strengthens its U.S. operations and further advances its long-term commitment to delivering high‑quality products, reliable supply, and an enhanced level of support to its customers and distribution partners. Noble Pharma significantly enhances Parnell’s manufacturing capabilities, improves supply continuity, and supports continued growth across the company’s expanding product portfolio.
Read the full article: Parnell Acquires Noble Pharma LLC, Expanding U.S. Manufacturing Capabilities //
Source: https://www.businesswire.com/news/home/20260407508290/en/Parnell-Acquires-Noble-Pharma-LLC-Expanding-U.S.-Manufacturing-Capabilities